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Background: Meticulous steps and procedures are proposed in planning guidelines for the development of
comprehensive multiyear plans for national immunization programmes. However, we know very little about
whether the real-life experience of those who adopt these guidelines involves following these procedures as
expected. Are these steps and procedures followed in practice? We examined the adoption and usage of the
guidelines in planning national immunization programmes and assessed whether the recommendations in these
guidelines are applied as consistently as intended.
Methods: We gathered information from the national comprehensive multiyear plans developed by 77 low-income
countries. For each of the 11 components, we examined how each country applied the four recommended steps
of situation analysis, problem prioritization, selection of interventions, and selection of indicators. We then
conducted an analysis to determine the patterns of alignment of the comprehensive multiyear plans with those
four recommended planning steps.
Results: Within the first 3 years following publication of the guidelines, 66 (86%) countries used the tool to develop
their comprehensive multiyear plans. The funding conditions attached to the use of these guidelines appeared to
influence their rapid adoption and usage. Overall, only 33 (43%) countries fully applied all four recommended
planning steps of the guidelines.
Conclusions: Adoption and usage of the guidelines for the development of comprehensive multiyear plans for
national immunization programmes were rapid. However, our findings show substantial variation between the
proposed planning ideals set out in the guidelines and actual use in practice. A better understanding of factors that
influence how recommendations in public health guidelines are applied in practice could contribute to
improvements in guidelines design. It could also help adjust strategies used to introduce them into public health
programmes, with the ultimate goal of a greater health impact.
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Whether considered as a staged or an iterative process,
public health policy and practice involve the use of
guidelines in planning and implementing interventions
[1,2]. These instruments provide the principles, proce-
dures, and techniques used in virtually every phase of
the implementation circle, from initiation to formula-
tion, implementation, and finally, evaluation of the out-
comes and impacts [3-7]. Even though systematic effort
to convert basic research knowledge to evidence-based
guidelines and practice is relatively new in public health
compared to clinical medicine [8,9], there is increasing
body of scientific literature and research on the use of
basic public health science and new discoveries in
public health policies and practice guidelines [9-15].
Additionally, instruments such as the Grading of
Recommendations Assessment, Development and Evalu-
ation (GRADE) framework are increasingly being used by
the public health community to appraise the quality of evi-
dence for public health recommendations and production
of public health guidelines [16,17].
The production of public health guidelines and their
effective use are two complementary aspects. We know
much about the types and number of public health
guidelines being produced. For example, the World
Health Organization (WHO) alone produces at least 20
public health guidelines annually. These guidelines in-
clude the global framework for immunization monitor-
ing and surveillance [18], the updated guidelines for
evaluating public health surveillance systems [19], the
guidelines for intensified tuberculosis case-finding and
isoniazid preventive therapy for people living with
HIV in resource-constrained settings [20], a compre-
hensive multiyear planning tool for immunization pro-
grammes [21], and the United Nations Children’s Fund
(UNICEF) cholera toolkit [22], among others. However,
there is very little information on whether or how these
tools are actually used in public health practice in
countries with varying political, economic, and social
systems [23].
The question of whether these tools are applied as
consistently as intended is not often addressed in pub-
lic health research. Despite this gap in knowledge, the
public health community generates and disseminates
public health guidelines without, in most instances,
critically assessing them and building on the experience
gained. Sometimes, the guidelines being released or
promoted by different public health agencies are more
or less the same, except for minor differences in ter-
minology and certain details. An assessment of how
recommendations and procedures of public guidelines
are followed in public health programmes is necessary
if the instruments are to add value to the health of pop-
ulations [24,25].Policy context for the study
Guidelines for the development of comprehensive multi-
year plans (cMYPs) for national immunization pro-
grammes were developed by the WHO, UNICEF, and
partners to support countries in implementing the
Global Immunization Vision and Strategy (GIVS). The
GIVS is a global immunizational policy framework that
was introduced in 2005 in order to enhance the impact
of immunization programmes and further reduce infant
mortality due to vaccine-preventable disease, particularly
in low-income countries [26,27]. These guidelines repre-
sent a new approach to immunization planning, guided
by the need to simplify and harmonize a large number
of immunization-planning activities at the national level.
They aim to assist countries in streamlining the im-
munization planning process at the national level into a
single comprehensive and budgeted plan and to minimize
the duplication of efforts and transaction costs for coun-
tries and partners [26].
The guidelines are based on the rational model of plan-
ning [28,29], which follows a logical process beginning with
situation analysis, followed by ranking and prioritization of
the problems identified, evaluation and selection of possible
interventions, and assessment of performance-monitoring
indicators and milestones [21,30,31]. The guidelines have
been in use since 2005, and the WHO and other partners
have played an active role in facilitating their adoption and
use through training workshops [32-34] and technical as-
sistance. Since the instrument was introduced, the GAVI
Alliance (Gavi) has required countries that applied for spe-
cific windows of funding to support their application with a
cMYP developed based on the guidelines [33]. The gross
national income (GNI) per capita threshold that was set to
establish eligibility for Gavi financial support was US$1,000
between 2000 and 2010; thereafter, it was adjusted to
US$1,500 [34].
In this study, we examined the patterns of adoption and
alignment of the cMYPs with the recommendations and
procedures of the guidelines in national immunization
programmes. The purpose of our study is to partially fill
the gap in knowledge between recommendations and pro-
cedures of public health guidelines and whether they are
followed among the target audience in public health
practice.
Methods
A document review was conducted on 77 countries that
had adopted the guidelines for the development of
cMYPs for national immunization programmes. The
WHO financing and planning database [35] was used to
identify countries that have developed at least one cMYP
based on the guidelines. This database is a repository of
copies of cMYPs developed by countries and shared with
the WHO. As of December 2012, 77 countries had
Figure 1 Trend of cMYP development using the guidelines by
countries from 2005 to 2011.
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including 54 that had developed a second cMYP. In
total, 77 copies of the first cMYPs were retrieved from
the database for review and data extraction.
The detailed data that were extracted from the cMYPs
included information on how the planning steps pro-
posed by the guidelines were applied by the countries in
each of the 11 national immunization planning compo-
nents identified. Those planning components include
the following 1) vaccine supply and stock management,
2) cold chain, 3) human resources, 4) vaccination imple-
mentation, 5) immunization safety, 6) adverse events
following immunization (AEFI), 7) waste management,
8) surveillance and laboratory analysis, 9) coordination
and supervision, 10) immunization promotion, and 11)
government funding.
A descriptive analysis was performed using the ex-
tracted data to determine adoption patterns and the ex-
tent to which countries followed the recommended
planning steps in the guidelines, as the tool was used by
different countries in the development of the cMYPs.
Alignment of the cMYPs with the recommended plan-
ning steps was assessed based on inclusion or omission
of the steps, as well as inclusion of a minimum set of in-
formation for the included steps. A step was considered
followed if a cMYP included the step and also, for the
first (situation analysis) step, at least one performance
gap was included; for the second (problem prioritization)
step, at least one national immunization programme pri-
ority was specified; for the third (intervention selection)
step, at least one national immunization programme
intervention was specified; and for a chosen intervention
in the fourth (indicator selection) step, at least one per-
formance indicator was specified.
Results
Among the 77 countries studied here, there was a rapid
increase in the number of countries that adopted the
guidelines and developed their first cMYPs based on
those guidelines, from 4 (5%) in 2005 to 66 (86%) by the
end of 2007. From 2008, 54 (70%) countries that reached
the end of the time period covered by their first cMYP
developed a second one; only one country developed a
second cMYP in 2008 and by 2011, a total of 54 coun-
tries had developed a second cMYP using the guidelines
(Figure 1).
Since 2005, Gavi-eligible countries have been required
to support their applications for specific windows of
funding with a cMYP developed using the guidelines. As
a result, all 72 (94%) countries that received Gavi sup-
port during the period studied developed a cMYP based
on the guidelines. As Gavi eligibility is based on GNI per
capita, the majority of countries that used the guidelines
were low-income countries. Another three countries (4%of those studied) used the guidelines to develop a cMYP,
although they were not eligible for Gavi support; those
countries include Namibia, Botswana, and Swaziland.
The WHO’s African region, with a high proportion of
Gavi-eligible, low-income countries, accounted for the
largest numbers of countries studied (N = 40, 52%)
(Table 1), followed by Southeast Asia (N = 9, 12%), the
Eastern Mediterranean (N = 8, 10%), Europe (N = 7,
10%), the Western Pacific (N = 7, 10%), and the Americas
(N = 6, 8%). The European, Western Pacific, and American
regions, including predominantly high-income countries,
had the lowest number of countries that used the guide-
lines to develop a cMYP.
We examined how rigorously the four planning steps
in the guidelines have been applied by the countries that
developed a cMYP (Table 2). The first step, situation
analysis, was the most followed among the 77 countries
that used the guidelines; 70% to 94% of the countries ap-
plied the situation analysis step in all 11 planning com-
ponents of the national immunization programme. The
second planning step, problem prioritization, was the
second most applied with 65% to 90% of the 77 coun-
tries applying the step in 10 of the 11 planning compo-
nents. In third position was the third planning step,
intervention selection, which showed 48% to 88% of the
77 countries applying the step in 10 of the 11 planning
components. The fourth planning step, indicator selec-
tion, had the lowest percentage of countries that aligned
their plans with the step, with 0% to 7% of the countries
applying the step in 10 of the 11 planning components.
The extent to which the four planning steps in the
guidelines were followed in the cMYPs developed by
the 77 countries was further examined based on indi-
vidual planning components; 3 categories were identi-
fied among the 11 planning components (Table 2). The
first category consisted of four components with the
highest proportion of countries (>60%) that followed all
four planning steps, which included the cold chain,
Table 1 Countries by WHO region developing at least one cMYP using the guidelines
Year AFR [n = 46] AMR [n = 35] EMR [n = 22] EUR [n = 53] SEAR [n = 11] WPR [n = 27] Total [n = 194]
2005 2 (2) _ 1 (1) _ 1 (1) _ 4 (4)
2006 11 (10) 1 (1) 2 (2) 1 (1) _ 4 (4) 19 (18)
2007 20 (19) 4 (3) 4 (4) 4 (4) 5 (5) 2 (2) 39 (37)
2008 5 (4) _ 1 2 (2) 1 (1) 1 (1) 10 (8)
2009 1 (1) 1 (1) _ _ 1 (1) _ 3 (3)
2010 1 (1) _ _ _ _ _ 1 (1)
2011 _ _ _ _ 1 (1) _ 1 (1)
Total 40 (37) 6 (5) 8 (7) 7 (7) 9 (9) 7 (7) 77 (72)
Numbers in parentheses indicate the number of countries with a GNI per capita income ≤ US$1,000 that were eligible for Gavi funding.
Abbreviations: AFR WHO African region, AMR WHO region of the Americas, EMR WHO Eastern Mediterranean region, EUR WHO European region, SEAR WHO South
East Asia region, WPR WHO Western Pacific region.
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cine supply and stock management planning. Vaccination
implementation had the highest number of countries that
followed all four planning steps in the development of
their cMYPs in this category, with 60 (78%) countries ap-
plying all four planning steps. The human resources plan-
ning component had the second highest number of
countries that followed all four planning steps, with 58
(75%) countries applying all four steps, followed by the
cold chain planning component, with 55 (71%) countries
applying all four planning steps. Finally, 54 (70%) coun-
tries applied all four steps in the vaccine supply and stock
management planning component in this category.
The second category consisted of four planning compo-
nents with 30% to 60% of the countries applying all four
planning steps of the guidelines. These planning com-
ponents included government funding, immunizationTable 2 Number of countries that followed the planning step
Immunization planning
component
Situation analysis
step
Problem prioritiza
step
>60% followed all four planning steps
1. Human resources 72 (94) 69 (90)
2. Cold chain 69 (90) 69 (90)
3. Vaccination implementation 63 (82) 60 (78)
4. Vaccine supply and stock
management
62 (81) 61 (79)
30% to 60% followed all four planning steps
5. Immunization safety 60 (78) 56 (73)
6. Waste management 59 (77) 57 (74)
7. Government funding 57 (74) 54 (70)
8. AEFI monitoring 56 (73) 50 (65)
<30% followed all four planning steps
9. Surveillance and laboratory 67 (87) 64 (83)
10. Immunization promotion 58 (75) 54 (70)
11. Coordination and supervision 54 (70) 53 (69)
Numbers in parentheses indicate the percentage of countries implementing the plasafety, waste management, and AEFI monitoring planning.
Immunization safety had the highest number of countries
that followed all four planning steps in this category, with
44 (57%) countries applying all four planning steps,
followed by government funding, with 33 (43%) countries
applying all four planning steps, and waste management,
with 31(40%) countries applying all four planning steps.
AEFI monitoring was in last position in this group, with
25 (32%) countries applying all four planning steps.
Finally, the third category contained three planning
components with <30% of the countries following all
four planning steps. These components included surveil-
lance and laboratory analysis, immunization promotion,
and coordination and supervision planning. Eight (10%)
countries applied all four planning steps of surveillance
and laboratory analysis. None of the countries proposed
intervention indicators, the fourth planning step, fors in the cMYP guidelines
tion Intervention selection
step
Indicator selection
step
Compliance with
all four steps
68 (88) 58 (75) 58 (75)
61 (79) 55 (71) 55 (71)
60 (78) 60 (78) 60 (78)
60 (78) 54 (70) 54 (70)
49 (64) 44 (57) 44 (57)
40 (52) 31 (40) 31 (40)
37 (48) 33 (43) 33 (43)
44 (57) 25 (32) 25 (32)
63 (82) 8 (10) 8 (10)
50 (65) 0 (0) 0 (0)
44 (57) 0 (0) 0 (0)
nning step(s).
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and supervision planning components in this category.
Discussion
The main findings show that a total of 77 countries have
adopted and used the guidelines for the development of
cMYPs for their national immunization programmes.
There was rapid adoption of the instrument, with 66
(86%) countries doing so within the first 3 years of its
introduction. Use of the guidelines appeared to be sus-
tained, as 54 (70%) countries had already used the instru-
ment to develop a second cMYP to cover a subsequent
time period.
Among the countries that adopted the guidelines, 72
(94%) were low-income countries, with a per capita
income not exceeding US$1,000. The African region
accounted for the highest percentage of countries that
used the guidelines (52%), followed by Southeast Asia
(12%). Adoption of the guidelines was minimal among
countries with higher incomes, given that only five
countries with a per capita income > US$1,000 adopted
the guidelines and that none of the high-income coun-
tries adopted the guidelines.
The findings that we have presented regarding the pat-
terns of adoption and use of the guidelines suggest that
the technical merits of the instrument alone were not
the only considerations in a country’s decision to adopt
and use the guidelines; other factors, such as economic
status and donor funding, and particularly the linkage of
an infusion of Gavi donor funds with use of the guide-
lines in the preparation of national immunization plans,
appeared to be influential. Between 2005 and 2010, eli-
gible countries with a per capita income not exceeding
US$1,000 were required by Gavi to support their fund-
ing applications with cMYPs based on the guidelines,
which may explain the increase in adoption mainly
among countries with the lowest incomes. Furthermore,
certain funding windows were only available within a
specific period of time, and the rush to secure funds be-
fore the windows closed most likely contributed to the
observed accelerated use of the guidelines among these
countries. These observations are consistent with studies
that have demonstrated the influence of fiscal context
and financial incentives on the accelerated adoption and
use of new health practice guidelines [36-38]. Even
though no funding was given as an incentive, the linkage
of funding to use of the guidelines in preparation of the
national immunization plans may have influenced the
decisions of countries to adopt the guidelines among
countries that needed to apply for these funds.
As we have indicated, despite the rapid pace of adop-
tion and use of the guidelines for cMYP development by
many countries, the recommended planning steps in the
guidelines were not systematically applied in the 77cMYPs analyzed. Situation analysis, the first planning
step, was the most applied among the countries. Subse-
quent planning steps were applied to a lesser extent,
with indicator selection step (the fourth planning step)
being the least respected.
Even though the alignment of the cMYPs with all four
planning steps in the guidelines, from situation analysis
to indicator selection, was generally satisfactory, much
higher levels of omission of the intervention and indica-
tor selection planning steps were observed in most of
the planning components. This result appears to suggest
that countries do not regard the choice of immunization
programme interventions and performance monitoring
very highly. Less emphasis on performance monitoring
has been observed in other public health programmes in
resource-poor settings [39], which may be explained by
the fact that, traditionally, the performance and success
of national immunization programmes have primarily
been measured in terms of the national vaccination im-
plementation and coverage achieved [40]. This idea is
consistent with the findings in this study, which showed
that the highest number of countries followed all four
planning steps in the vaccination implementation plan-
ning component compared with the other ten planning
components of national immunization programmes.
An examination of how the planning steps were
followed in specific planning components further revealed
better alignment with the four planning steps of the
planning components that come under direct control of
immunization programme managers; over 60% of the
countries followed all four steps in these planning compo-
nent, which included cold chain, human resources, vaccin-
ation implementation, and vaccine supply and stock
management planning components. Comparatively, align-
ment of the cMYPs with the planning steps of the guide-
lines was relatively lower among planning components
that are shared with other technical units; these compo-
nents include surveillance and laboratory analysis, which
is a core function of epidemiology and public health la-
boratories units of the MOH; immunization promotion,
which is often shared with health promotion units of the
MOH; government funding for immunization, which is a
function of the national budgeting office; and waste man-
agement, which may depend on the sanitation depart-
ment. It is not clear whether this result was because
immunization programme managers are less committed
to, or not as experienced with, planning components that
are shared with other technical units. However, planning
experience has been shown to influence the quality of
planning [41].
Conclusions
This study reveals some gaps between the recommended
ideals of the cMYP guidelines and the application of the
Mala et al. Implementation Science  (2015) 10:48 Page 6 of 7recommendations in actual practice. While the main
limitation of this analysis was a lack of information on
the possible explanatory factors for the observed gaps,
ensuring the continued use and consistent application of
recommendations and procedures of the guidelines by
national immunization programmes calls for further
studies to gain a better understanding of the factors con-
tributing to these gaps in the diverse economic, political,
and social contexts of the implementing countries. This
understanding could contribute to the development of
better guidelines, more effective introduction strategies,
and ultimately more respect for their recommendations
among users for greater public health impact.
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